Targeted Hyperpolarized Molecular Beacons for Colorectal Cancer Detection
用于结直肠癌检测的靶向超极化分子信标
基本信息
- 批准号:10696093
- 负责人:
- 金额:$ 20.25万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-30 至 2024-07-31
- 项目状态:已结题
- 来源:
- 关键词:AcidsAffinityAmmoniaAnimal Cancer ModelAnimal ModelAnimalsAntibodiesAntibody AffinityAntibody SpecificityBindingBiological AssayBiological MarkersBlood CirculationBlood VesselsCancer DetectionCarbonCarbon DioxideCause of DeathCell surfaceCirculationColorectal CancerDetectionDiameterEarly DiagnosisEnzymesEventHourHumanHydrolysisImageLabelLesionMagnetic ResonanceMagnetic Resonance ImagingMalignant NeoplasmsMembrane GlycoproteinsMetabolicMethodologyMolecularMolecular TargetMucinsNational Institute of Biomedical Imaging and BioengineeringNeoplasm MetastasisPhenotypePlantsPrognosisProliferatingProteinsReactionRelaxationReporterSignal TransductionSiteSystemTandem Repeat SequencesTechniquesTechnologyTimeTissue imagingUnited StatesUreaUreasecancer carecancer therapycolorectal cancer screeningdetection methoddetection sensitivityexperimental studyextracellularin vivo imaginginnovationinterestmolecular imagingnanoparticlepatient populationpatient prognosisreceptorsmall moleculespectroscopic imagingtumor
项目摘要
ABSTRACT
Colorectal cancer is the third leading cause of death in the United States. Early diagnosis is central to cancer
care. Often, only tumors greater than 5 mm can be imaged using existing technologies, limiting the ability of early
diagnosis. Our proposed constructs, "hyperpolarized molecular beacons,” will significantly increase the ability of
detecting cancer by utilizing several amplification steps and combining the versatile binding affinity and specificity
of antibodies with the sensitivity of hyperpolarized Magnetic Resonance (HP MR). Antibodies have high affinity
to their protein targets, and several are approved for cancer treatment. Hyperpolarized molecular beacons will
utilize antibody based molecular targeting and leverage >10,000-fold sensitivity enhancement by hyperpolarized
MR technique to create a highly sensitive early detection method forcolorectal cancer. In a HP molecular beacon,
an antibody is attached to a protein that catalyzes the conversion of hyperpolarized small molecules; therefore,
metabolites of the hyperpolarized compounds are only observed in the presence of the reporter. We will attach
a plant based protein to the N-terminus of an antibody that recognizes human mucin protein (MUC1). MUC1
protein positively correlates with tumor proliferation, invasiveness, and metastasis in colorectal cancer. Our
proposed MUC1 antibody specifically recognizes a large section of MUC1. The HP molecular beacon will
enhance signal amplitude through multiple MUC1 antibodies binding to one MUC1 protein, catalytic amplification
of the signal and enhancement through the use of hyperpolarization. We will therefore, create a high affinity
MUC1 targeted hyperpolarized molecular beacon, evaluate its ability to detect colorectal cancer in animal models
and will expand the repertoire of HP molecular beacons to other cell surface markers to develop a multiplexed
molecular beacon to recognize the full repertoire of colorectal cancer phenotypes in diverse patient populations.
This methodology will significantly increase the capability of targeted molecular imaging in MRI and can be
readily replicated with other antibodies in different cancer systems.
抽象的
结直肠癌是美国第三大死亡原因,早期诊断对于癌症至关重要。
通常,使用现有技术只能对大于 5 毫米的肿瘤进行成像,这限制了早期诊断的能力。
我们提出的“超极化分子信标”结构将显着提高诊断能力。
通过利用多个扩增步骤并结合多功能结合亲和力和特异性来检测癌症
具有超极化磁共振 (HP MR) 敏感性的抗体具有高亲和力。
超极化分子信标将用于癌症治疗。
利用基于抗体的分子靶向,并利用超极化使灵敏度提高 >10,000 倍
MR 技术创建了一种高灵敏度的结直肠癌早期检测方法 在 HP 分子信标中,
抗体附着在催化超极化小分子转化的蛋白质上;
超极化化合物的代谢物仅在报告者存在的情况下才能观察到,我们将附上。
一种植物蛋白连接到识别人粘蛋白蛋白 (MUC1) 的抗体的 N 端。
蛋白质与结直肠癌的肿瘤增殖、侵袭性和转移呈正相关。
提出的 MUC1 抗体特异性识别 MUC1 的大部分 HP 分子信标。
通过多种 MUC1 抗体与一种 MUC1 蛋白结合,催化放大,增强信号幅度
因此,我们将通过使用超极化来增强信号和增强亲和力。
MUC1靶向超极化分子信标,评估其在动物模型中检测结直肠癌的能力
并将将 HP 分子信标的全部范围扩展到其他细胞表面标记,以开发多路复用
分子信标可识别不同患者群体中结直肠癌表型的全部信息。
该方法将显着提高 MRI 中靶向分子成像的能力,并且可以
很容易在不同的癌症系统中与其他抗体一起复制。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Post-Acquisition Hyperpolarized 29Silicon Magnetic Resonance Image Processing for Visualization of Colorectal Lesions Using a User-Friendly Graphical Interface.
使用用户友好的图形界面进行采集后超极化 29 硅磁共振图像处理,实现结直肠病变的可视化。
- DOI:
- 发表时间:2022-03-01
- 期刊:
- 影响因子:0
- 作者:McCowan, Caitlin V;Salmon, Duncan;Hu, Jingzhe;Pudakalakatti, Shivanand;Whiting, Nicholas;Davis, Jennifer S;Carson, Daniel D;Zacharias, Niki M;Bhattacharya, Pratip K;Farach
- 通讯作者:Farach
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Pratip K. Bhattacharya其他文献
Unlocking ferroptosis in prostate cancer - the road to novel therapies and imaging markers.
解开前列腺癌的铁死亡——新疗法和成像标记物之路。
- DOI:
10.1038/s41585-024-00869-9 - 发表时间:
2024-04-16 - 期刊:
- 影响因子:0
- 作者:
Pham Hong Anh Cao;Abishai Dominic;Fabiola Ester Lujan;Sanjanaa Senthilkumar;Pratip K. Bhattacharya;Daniel E. Frigo;Elavarasan Subramani - 通讯作者:
Elavarasan Subramani
Pratip K. Bhattacharya的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Pratip K. Bhattacharya', 18)}}的其他基金
Targeted Hyperpolarized Molecular Beacons for Colorectal Cancer Detection
用于结直肠癌检测的靶向超极化分子信标
- 批准号:
10371429 - 财政年份:2021
- 资助金额:
$ 20.25万 - 项目类别:
Targeted Hyperpolarized Molecular Beacons for Colorectal Cancer Detection
用于结直肠癌检测的靶向超极化分子信标
- 批准号:
10495268 - 财政年份:2021
- 资助金额:
$ 20.25万 - 项目类别:
(PQC5)Early Detection Pancreatic Cancer by Hyperpolarized Silicon Nanoparticles
(PQC5)超极化硅纳米颗粒早期检测胰腺癌
- 批准号:
8687422 - 财政年份:2014
- 资助金额:
$ 20.25万 - 项目类别:
(PQC5)Early Detection Pancreatic Cancer by Hyperpolarized Silicon Nanoparticles
(PQC5)超极化硅纳米颗粒早期检测胰腺癌
- 批准号:
8841697 - 财政年份:2014
- 资助金额:
$ 20.25万 - 项目类别:
相似国自然基金
抗原非特异性B细胞进入生发中心并实现亲和力成熟的潜力与调控机制
- 批准号:32370941
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
面向免疫疗法标志物识别的基于多特征融合的肽与MHC亲和力预测研究
- 批准号:62302277
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于胞内蛋白亲和力标记策略进行新型抗类风湿性关节炎的选择性OGG1小分子抑制剂的发现
- 批准号:82304698
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于计算生物学技术小分子农兽药残留物驼源单域抗体虚拟筛选与亲和力成熟 -以内蒙古阿拉善双峰驼为例
- 批准号:32360190
- 批准年份:2023
- 资助金额:34 万元
- 项目类别:地区科学基金项目
DNA四面体限域辅助的高亲和力铅笔芯微电极用于早期癌症精准诊断研究
- 批准号:22304062
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Targeted Hyperpolarized Molecular Beacons for Colorectal Cancer Detection
用于结直肠癌检测的靶向超极化分子信标
- 批准号:
10371429 - 财政年份:2021
- 资助金额:
$ 20.25万 - 项目类别:
Targeted Hyperpolarized Molecular Beacons for Colorectal Cancer Detection
用于结直肠癌检测的靶向超极化分子信标
- 批准号:
10495268 - 财政年份:2021
- 资助金额:
$ 20.25万 - 项目类别:
Identifying SREBP-1 activation mechanism in glioblastoma and its new role in regulating glutamine metabolism
鉴定胶质母细胞瘤中SREBP-1的激活机制及其在调节谷氨酰胺代谢中的新作用
- 批准号:
10553204 - 财政年份:2020
- 资助金额:
$ 20.25万 - 项目类别:
Identifying SREBP-1 activation mechanism in glioblastoma and its new role in regulating glutamine metabolism
鉴定胶质母细胞瘤中SREBP-1的激活机制及其在调节谷氨酰胺代谢中的新作用
- 批准号:
10334514 - 财政年份:2020
- 资助金额:
$ 20.25万 - 项目类别:
Photoredox-Enabled Applications of Primary Amines as Alkylating Reagents
伯胺作为烷基化试剂的光氧化还原应用
- 批准号:
9978569 - 财政年份:2019
- 资助金额:
$ 20.25万 - 项目类别: